BICO Group

BICO Group
About Us
Change country

Follow us:
Share:
Subscribe:

About Us

Founded in 2016, BICO (formerly CELLINK) is the leading Bio Convergence company in the world by combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health. The Group’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,000 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com

CELLINK Bioprinting moves to Entré Kallebäck

Mon, May 24, 2021 08:00 CET

CELLINK’s successful and innovation driven Bioprinting business is in an exciting development phase and will from the beginning of 2022 relocate to the newly built Entré Kallebäck in Gothenburg. The relocation involves co-location of the Swedish part of the business under one roof – from research & development to production and sales and marketing.CELLINK Bioprinting will be the anchor tenant of the building which is strategically located in expansive Kallebäck in central Gothenburg. The newly built property will provide seamless integration in premises that are adapted to the company’s

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Links

CELLINK Bioprinting moves to Entré Kallebäck